Surgical and chemotherapeutic cytoreduction for advanced primary and recurrent ovarian cancer , the Washington Cancer Institute approach

@inproceedings{Sugarbaker2010SurgicalAC,
  title={Surgical and chemotherapeutic cytoreduction for advanced primary and recurrent ovarian cancer , the Washington Cancer Institute approach},
  author={Paul H Sugarbaker},
  year={2010}
}
Ovarian cancer remains the number one cause of death from gynecological malignancies. Currently, the conventional treatment approach for advanced (stage III and IV) ovarian malignancy is surgical debulking and systemic chemotherapy. Negative second-look laparotomy is attainable in only 20 to 40% of the cases. Up to 47% of these patients relapse within 5… CONTINUE READING